Short Interest To Observe: Time to Reconsider Delcath Systems Incorporated (NASDAQ:DCTH) After More Short Sellers?

December 1, 2016 - By Hazel Jackson   ·   0 Comments

Short Interest To Observe: Time to Reconsider Delcath Systems Incorporated (NASDAQ:DCTH) After More Short Sellers?

The stock of Delcath Systems Incorporated (NASDAQ:DCTH) registered an increase of 0.42% in short interest. DCTH’s total short interest was 215,100 shares in December as published by FINRA. Its up 0.42% from 214,200 shares, reported previously. With 29,800 shares average volume, it will take short sellers 7 days to cover their DCTH’s short positions. The short interest to Delcath Systems Incorporated’s float is 15.43%. The stock increased 2.45% or $0.05 during the last trading session, hitting $2.09. Delcath Systems, Inc. (NASDAQ:DCTH) has declined 59.18% since April 28, 2016 and is downtrending. It has underperformed by 65.11% the S&P500.

Delcath Systems, Inc. is a late-stage clinical development firm with early commercial activity in Europe focused on cancers of the liver. The company has a market cap of $4.13 million. The Firm is a specialty pharmaceutical and medical device firm developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System . It currently has negative earnings. The Company’s system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT).

Insitutional Activity: The institutional sentiment decreased to 0 in 2016 Q2. Its down 1.13, from 1.13 in 2016Q1. The ratio worsened, as 7 funds sold all Delcath Systems, Inc. shares owned while 1 reduced positions. 2 funds bought stakes while 7 increased positions. They now own 1.85 million shares or 18.13% less from 2.26 million shares in 2016Q1.
Group One Trading L P accumulated 0% or 5,123 shares. Deutsche Commercial Bank Ag reported 5 shares or 0% of all its holdings. Blackrock Institutional Company Na accumulated 0% or 531,871 shares. Citadel Advsr Limited Liability Co accumulated 0% or 157,333 shares. Private Advisor Gp Ltd Liability Company accumulated 0% or 206,670 shares. Geode Mngmt Limited Liability Com reported 39,792 shares or 0% of all its holdings. Renaissance Ltd Liability has 754,998 shares for 0% of their US portfolio. Barclays Public Limited Co owns 15 shares or 0% of their US portfolio. The Kansas-based Creative Planning has invested 0% in Delcath Systems, Inc. (NASDAQ:DCTH). Susquehanna Int Grp Inc Ltd Liability Partnership holds 0% of its portfolio in Delcath Systems, Inc. (NASDAQ:DCTH) for 39,047 shares. Blackrock Fund Advsrs has 0% invested in the company for 4,024 shares. Ladenburg Thalmann Financial Service has 0% invested in the company for 1,456 shares. Wells Fargo Commerce Mn has invested 0% of its portfolio in Delcath Systems, Inc. (NASDAQ:DCTH). Kcg Hldgs holds 0% of its portfolio in Delcath Systems, Inc. (NASDAQ:DCTH) for 12,403 shares. Royal State Bank Of Canada, a Ontario – Canada-based fund reported 2,563 shares.

DCTH Company Profile

Delcath Systems, Inc., incorporated on August 5, 1988, is a late-stage clinical development firm with early commercial activity in Europe focused on cancers of the liver. The Firm is a specialty pharmaceutical and medical device firm developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company’s system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company’s focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

More recent Delcath Systems, Inc. (NASDAQ:DCTH) news were published by: Marketwatch.com which released: “Delcath Systems Inc.” on December 22, 2009. Also Finance.Yahoo.com published the news titled: “Delcath Systems to Present at the 9th Annual LD Micro Main Event” on November 30, 2016. Prnewswire.com‘s news article titled: “Delcath Issues Letter to Stockholders” with publication date: October 18, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>